Your browser doesn't support javascript.
loading
Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools.
Chan, Waipan; Gottschalk, Rachel A; Yao, Yikun; Pomerantz, Joel L; Germain, Ronald N.
Afiliação
  • Chan W; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; waipan.chan@nih.gov rgermain@niaid.nih.gov.
  • Gottschalk RA; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Yao Y; Molecular Development of the Immune System Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and.
  • Pomerantz JL; Department of Biological Chemistry and Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Germain RN; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; waipan.chan@nih.gov rgermain@niaid.nih.gov.
Immunohorizons ; 5(2): 117-132, 2021 02 23.
Article em En | MEDLINE | ID: mdl-33622708
ABSTRACT
Clustered regularly interspaced short palindromic repeats (CRISPR)-based methods have revolutionized genome engineering and the study of gene-phenotype relationships. However, modifying cells of the innate immune system, especially macrophages, has been challenging because of cell pathology and low targeting efficiency resulting from nucleic acid activation of intracellular sensors. Likewise, lymphocytes of the adaptive immune system are difficult to modify using CRISPR-enhanced homology-directed repair because of inefficient or toxic delivery of donor templates using transient transfection methods. To overcome these challenges and limitations, we modified existing tools and developed three alternative methods for CRISPR-based genome editing using a hit-and-run transient expression strategy, together with a convenient system for promoting gene expression using CRISPRa. Overall, our CRISPR tools and strategies designed to tackle both murine and human immune cell genome engineering provide efficient alternatives to existing methods and have wide application not only in terms of hematopoietic cells but also other mammalian cell types of interest.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marcação de Genes / Sistemas CRISPR-Cas / Edição de Genes / Sistema Imunitário Limite: Animals / Humans Idioma: En Revista: Immunohorizons Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marcação de Genes / Sistemas CRISPR-Cas / Edição de Genes / Sistema Imunitário Limite: Animals / Humans Idioma: En Revista: Immunohorizons Ano de publicação: 2021 Tipo de documento: Article